export const sampleAiResponses = [
  "ðŸŽ¯ **ABC Segmentation - Critical Medicines**: Class A items (Insulin SKU004, Azithromycin SKU002, Amoxicillin SKU005) represent 68.5% of revenue (â‚¹52.8Cr) but show 12% forecast variance in Delhi and Mumbai hospitals. Recommend daily inventory reviews and dynamic safety stock buffers (+22% for Q1 2025) to prevent stockouts of life-saving medications worth â‚¹2.4Cr.",
  "ðŸ“ˆ **Seasonal Disease Pattern Intelligence**: Epidemiological data shows 42% surge in respiratory medication demand during winter months (Nov-Feb) with flu_index peaking at 0.88. Dengue medications spike 6x during monsoon (Jul-Sep) when dengue_index reaches 0.60. Action: Pre-position Salbutamol (SKU007) and Azithromycin (SKU002) inventory 4 weeks ahead.",
  "ðŸŒ **Channel Performance - E-Pharmacy Growth**: E-pharmacy channel growing at 35% CAGR vs 8% for traditional retail pharmacies. Chronic disease medications (Insulin SKU004, Pantoprazole SKU010) show 82% e-pharmacy preference among urban millennials. Reallocate 30% inventory to e-pharmacy fulfillment to capture â‚¹4.8Cr incremental revenue.",
  "âš•ï¸ **Generic Drug Launch Alert - Cholecalciferol**: Generic Vitamin D3 launch in Nov 2025 will trigger 18% volume surge and 12% price erosion. D3Max (SKU008) faces competition. Secure API supply now, increase production by 25%, and build 8 weeks safety stock to capture market opportunity before competition intensifies.",
  "ðŸ¥ **Hospital vs Retail Dynamics**: Large hospital chains (Apollo, Fortis) show 22% better forecast accuracy due to procurement system integration. Independent pharmacies exhibit 38% demand volatility. Deploy institution-specific models for Ceftriaxone (SKU009) and Insulin (SKU004) to improve MAPE by 3.8 points.",
  "ðŸ“Š **Cold Chain Compliance - Temperature-Sensitive SKUs**: XYZ segmentation identifies Insulin Glargine (SKU004) as high-variability cold chain SKU. 32% spoilage risk during monsoon (humidity_index > 0.70) in coastal regions. Implement IoT temperature monitoring and increase cold storage capacity by 25%.",
  "ðŸ’Š **Chronic vs Acute Planning**: Chronic medications (Diabetes SKU004, GI SKU010) show predictable 8-12 week refill cycles with 94% adherence. Acute care drugs (Antibiotics SKU002, SKU005) exhibit 250% demand volatility during outbreak weeks. Implement auto-refill programs for chronic meds to lock in â‚¹18Cr recurring revenue.",
  "ðŸš¨ **Disease Outbreak Alert - Monsoon Season**: Disease outbreak data shows Dengue cases in Maharashtra (13,634 in Jul W4) and Chikungunya spike in Delhi (12,110 in Jul W5). Pre-position ORS (SKU006), Paracetamol (SKU001), and Cetirizine (SKU003) in affected regions immediately.",
  "ðŸ’° **Medical Conference Impact**: API Annual Conference (Feb 16-18, New Delhi) historically drives 2% Rx uplift. Diabetology Congress (Nov 22-24, Hyderabad) expected to boost Insulin (SKU004) prescriptions by 2%. Align field force coverage and inventory with conference calendar.",
  "ðŸ”„ **Healthcare Policy Impact**: NPPA price cap update (Feb 10) affects Analgesic/Antibiotic category with expected -3% demand impact. However, insurance OPD pilot expansion (Apr 1) will boost Diabetes/GI medications by +6%. Adjust Paracetamol (SKU001) and Pantoprazole (SKU010) forecasts accordingly."
];